Peptide Advocates Want Fewer FDA Restrictions. But Where’s the Safety Data?
With a background in peptide research, I wanted to understand the science behind the push for greater access. At PepMed 2026, I found an enthusiastic industry, and significant…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 27 12:25 ETSource: MedShadow Foundation
From the source
Read at medshadow.orgPeptide Advocates Want Fewer FDA Restrictions. But Where’s the Safety Data?
With a background in peptide research, I wanted to understand the science behind the push for greater access. At PepMed 2026, I found an enthusiastic industry, and significant gaps in the evidence
